Skip to main content
. 2022 Mar 2;23(5):2766. doi: 10.3390/ijms23052766

Figure 6.

Figure 6

Structures of dopamine receptor ligands and of the designed fentanyl-based MOR/D2R MTAs. In red marked are fragments characteristic for D2R-ligands.